Incyte Corporation — FY2020 H-1B Filings

Incyte Corporation filed 3 H-1B LCAs in FY2020. Average salary: $104k.

In FY FY2020, Incyte Corporation filed 3 H-1B petitions with an average salary of $104k. Top positions include Lead Biostatistical Programmer (33%), Research Expert, Bioinformatics (33%), Biologics, CMC Writer (33%). Filings were concentrated in Delaware (100%). The certification rate was 100%. Salaries ranged from $90k to $123k.

3
Filings
$104k
Avg Salary
100%
Approval Rate
$100k
Median Salary

Prevailing Wage Analysis — FY2020

100% of filings offer salaries above the prevailing wage, with an average premium of 37.5%. The average prevailing wage is $77k (based on 3 filings).

Processing Time — FY2020

Average processing time is 135 days (median: 135 days). Fastest: 135 days, slowest: 135 days. Based on 1 filings.

Workforce Insights — FY2020

33% of filings are for new positions, while 0% are for continued employment (3 filings).

Average contract duration: 36 months (median: 36 months), based on 3 filings.

Education Requirements — FY2020

Education LevelFilings
Not Specified3

Top Job Titles in FY2020

Job TitleFilings
Lead Biostatistical Programmer1
Research Expert, Bioinformatics1
Biologics, CMC Writer1

All FY2020 Filings

Lead Biostatistical Programmer — Wilmington, DE
$123k · Certified - Withdrawn
Research Expert, Bioinformatics — Wilmington, DE
$100k · Certified - Withdrawn
Biologics, CMC Writer — Wilmington, DE
$90k · Certified - Withdrawn

Other Years

Related Pages

Immigration Guides

Frequently Asked Questions

How many H-1B filings did Incyte Corporation make in FY2020?

Incyte Corporation filed 3 H-1B Labor Condition Applications (LCAs) in FY2020.

What was Incyte Corporation's average H-1B salary in FY2020?

The average H-1B salary at Incyte Corporation in FY2020 was $104k.

What jobs did Incyte Corporation sponsor in FY2020?

The top H-1B job titles sponsored by Incyte Corporation in FY2020 include Lead Biostatistical Programmer, Research Expert, Bioinformatics, Biologics, CMC Writer.